Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study

PURPOSE: We previously demonstrated that 12 months of aromatase inhibitor (AI) treatment was not associated with a difference in body composition or other markers of cardiometabolic health when compared to controls. Here we report on the pre-planned extension of the study. The pre-specified primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Yee-Ming M, Hoermann, Rudolf, Van, Karen, Wu, Damian, Healy, Jenny, Halim, Bella, Raval, Manjri, McGill, Maria, Al-Fiadh, Ali, Chao, Michael, White, Shane, Yeo, Belinda, Zajac, Jeffrey D, Grossmann, Mathis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503251/
https://www.ncbi.nlm.nih.gov/pubmed/37522858
http://dx.doi.org/10.1530/EC-23-0076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503251/
https://www.ncbi.nlm.nih.gov/pubmed/37522858
http://dx.doi.org/10.1530/EC-23-0076

Ejemplares similares